In vitro, miR-21, by targeting the tumor suppressor Kruppel-like factor 5 (KLF5), promoted hepatic cancer cells’ invasiveness, as well as cancer progression, by inducing HCC cells to secrete angiogenic mediators, including VEGF [27]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.